SB1053, titled the Foreign Investment Guardrails to Help Thwart China Act of 2025 or the FIGHT China Act of 2025, would create a new federal framework to restrict certain U.S. investments tied to the People’s Republic of China and related entities. The bill authorizes the President, acting through the Treasury Secretary, to impose sanctions on covered foreign persons connected to China’s defense, surveillance, and related technology sectors, including blocking property and transactions under the International Emergency Economic Powers Act. It also requires Treasury to report to Congress on entities on the Non-SDN Chinese Military-Industrial Complex Companies List and on whether they qualify as covered foreign persons.
The bill would amend the Defense Production Act to prohibit or require notification for certain U.S. investments in “covered national security transactions” involving prohibited or notifiable technologies. Those technologies include advanced semiconductors, artificial intelligence, quantum computing and sensing, hypersonics, supercomputing, and other sensitive sectors. The measure also creates a notification regime, civil penalties, divestment authority, confidentiality protections, and a process for non-binding feedback and self-disclosure. It further directs Treasury and Commerce to issue regulations, coordinate with Congress, and engage allies on similar investment restrictions.
In addition, SB1053 would require U.S. persons to divest from securities of entities on the Non-SDN Chinese Military-Industrial Complex Companies List after a transition period, subject to waiver authority for national security or foreign policy reasons. The bill also directs Treasury to consider whether additional PRC-linked entities should be added to that list based on other federal lists, such as the Commerce Entity List and the Military End-User List. The legislation would terminate if Commerce removes China from the federal foreign adversaries list in the relevant regulations.
The overall sentiment reflected in the bill’s sponsorship is strongly supportive of a tougher national-security posture toward China, and the bipartisan set of original cosponsors suggests cross-party interest in the measure. No committee transcript or recorded vote is provided, so there is no documented floor or committee debate to indicate broader opposition or support beyond the bill’s text and sponsorship. The structure of the bill also shows an effort to balance restriction with compliance flexibility, including waivers, notice-and-comment rulemaking, and limited exceptions for ordinary financial and government activities.
The main points of potential contention are likely to be the breadth of the investment restrictions, the scope of technologies covered, and the administrative burden on U.S. investors and financial institutions. The bill gives Treasury significant discretion to define and update prohibited and notifiable technologies, which could raise concerns about regulatory uncertainty. At the same time, supporters would likely emphasize the national-security rationale, while critics may focus on possible effects on capital markets, private equity, venture capital, and U.S.-China economic ties.
SB1053 would significantly expand federal authority over outbound U.S. investment into China-linked sectors by adding a new title to the Defense Production Act and by authorizing sanctions under IEEPA against covered Chinese persons. It would also require divestment from certain Chinese military-industrial securities, create mandatory notification and prohibition regimes for sensitive transactions, and direct Treasury and Commerce to issue implementing regulations, reports, and coordination mechanisms. The bill would affect U.S. persons, financial institutions, investors, and companies operating in semiconductors, AI, quantum, hypersonics, and related advanced technology sectors, while also affecting federal agencies responsible for sanctions, export controls, and national security review.
The bill appears to be framed and introduced in a strongly pro-national-security, anti-China posture, with bipartisan sponsorship indicating at least initial support across party lines. Because there are no committee transcripts or votes provided, there is no recorded public debate in the supplied materials showing organized opposition or amendment activity. The text itself suggests an attempt to make the policy more workable by including waivers, feedback mechanisms, and compliance-minimizing rulemaking, which may have been intended to broaden support among investors and regulated entities.
Likely areas of contention include whether the bill is too broad in defining covered foreign persons and prohibited technologies, whether Treasury should have so much discretion to expand or refine the covered categories, and whether the investment restrictions could overreach into ordinary commercial activity. Financial firms, venture capital and private equity investors, and multinational companies could object to compliance costs, reporting obligations, divestment requirements, and uncertainty around what transactions are prohibited or merely notifiable. Supporters, by contrast, are likely to argue that the restrictions are necessary to prevent U.S. capital from supporting Chinese military, surveillance, and advanced technology development.